JAMP Temozolomide Recall Due to Out-of-Specification Assay
Areazine synthesizes this Health Canada recall directly from Health Canada's official public data feed. See our methodology for full source attribution and refresh cadence.
Health Canada recalls one lot of JAMP Temozolomide 140 mg capsules because the active ingredient is out of specification.
What this Health Canada recall tells you, and what most readers miss
This notice was issued by Health Canada on August 31, 2026 and geographically references Canada. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - Product & Food Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, health-canada, health-product.
What Happened
The active ingredient (temozolomide) in the affected lot is out of specification.
Which Products Are Affected
- Brand: JAMP Pharma Corporation
- Product Name: JAMP Temozolomide
- DIN: 02516829
- Dosage Form: Capsule
- Strength: 140 mg
- Lot Number: RLTS0225A
Depth of recall: Retailers.
What You Should Do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects or safety complaints to Health Canada.
Why This Matters
An out-of-specification assay for the active ingredient may affect product efficacy for patients relying on this medication.
Source
Health Canada - Published 2026-08-31
Original source: Health Canada Official Notice ↗
Related Product & Food Recalls
All Product & Food Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this Health Canada recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (934 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to August 31, 2026.
Frequently Asked Questions
Common questions about this Health Canada recall.